Laboratory Corporation of America Holdings (LH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Laboratory Corporation of America Holdings (LH) has a cash flow conversion efficiency ratio of 0.044x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($387.20 Million) by net assets ($8.71 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Laboratory Corporation of America Holdings - Cash Flow Conversion Efficiency Trend (1989–2024)
This chart illustrates how Laboratory Corporation of America Holdings's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read LH total liabilities for a breakdown of total debt and financial obligations.
Laboratory Corporation of America Holdings Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Laboratory Corporation of America Holdings ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chongqing Sokon Ind Grp Co
SHG:601127
|
0.287x |
|
Kuehne & Nagel
SW:KNIN
|
0.210x |
|
Guangdong Songfa Ceramics Co
SHG:603268
|
-0.057x |
|
Quest Diagnostics Incorporated
NYSE:DGX
|
0.064x |
|
Royalty Pharma Plc
NASDAQ:RPRX
|
0.085x |
|
China Everbright Bank Co Ltd
SHG:601818
|
0.275x |
|
Wipro Limited
F:WIOA
|
0.039x |
|
Hapag Lloyd AG
XETRA:HLAG
|
0.038x |
Annual Cash Flow Conversion Efficiency for Laboratory Corporation of America Holdings (1989–2024)
The table below shows the annual cash flow conversion efficiency of Laboratory Corporation of America Holdings from 1989 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Laboratory Corporation of America Holdin worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $8.07 Billion | $1.59 Billion | 0.197x | +16.83% |
| 2023-12-31 | $7.89 Billion | $1.33 Billion | 0.168x | -12.98% |
| 2022-12-31 | $10.12 Billion | $1.96 Billion | 0.193x | -35.99% |
| 2021-12-31 | $10.29 Billion | $3.11 Billion | 0.302x | +33.79% |
| 2020-12-31 | $9.46 Billion | $2.14 Billion | 0.226x | +18.18% |
| 2019-12-31 | $7.56 Billion | $1.44 Billion | 0.191x | +2.31% |
| 2018-12-31 | $6.99 Billion | $1.31 Billion | 0.187x | -14.01% |
| 2017-12-31 | $6.72 Billion | $1.46 Billion | 0.217x | +1.97% |
| 2016-12-31 | $5.52 Billion | $1.18 Billion | 0.213x | +11.47% |
| 2015-12-31 | $5.14 Billion | $982.40 Million | 0.191x | -26.62% |
| 2014-12-31 | $2.84 Billion | $739.00 Million | 0.260x | -21.09% |
| 2013-12-31 | $2.48 Billion | $818.70 Million | 0.330x | +7.95% |
| 2012-12-31 | $2.75 Billion | $841.40 Million | 0.306x | -9.84% |
| 2011-12-31 | $2.52 Billion | $855.60 Million | 0.339x | +1.10% |
| 2010-12-31 | $2.63 Billion | $883.60 Million | 0.335x | -12.57% |
| 2009-12-31 | $2.25 Billion | $862.40 Million | 0.384x | -11.12% |
| 2008-12-31 | $1.81 Billion | $780.90 Million | 0.432x | +4.91% |
| 2007-12-31 | $1.73 Billion | $709.70 Million | 0.411x | +28.62% |
| 2006-12-31 | $1.98 Billion | $632.30 Million | 0.320x | +5.03% |
| 2005-12-31 | $1.89 Billion | $574.20 Million | 0.305x | +11.71% |
| 2004-12-31 | $1.97 Billion | $538.10 Million | 0.273x | -8.42% |
| 2003-12-31 | $1.90 Billion | $564.30 Million | 0.298x | +9.92% |
| 2002-12-31 | $1.64 Billion | $444.90 Million | 0.271x | -7.00% |
| 2001-12-31 | $1.09 Billion | $316.00 Million | 0.291x | +3.54% |
| 2000-12-31 | $877.40 Million | $246.70 Million | 0.281x | +14.37% |
| 1999-12-31 | $734.20 Million | $180.50 Million | 0.246x | +33.87% |
| 1998-12-31 | $681.20 Million | $125.10 Million | 0.184x | -19.88% |
| 1997-12-31 | $630.00 Million | $144.40 Million | 0.229x | +131.67% |
| 1996-12-31 | $258.10 Million | $-186.80 Million | -0.724x | -733.82% |
| 1995-12-31 | $411.60 Million | $47.00 Million | 0.114x | +28.95% |
| 1994-12-31 | $166.00 Million | $14.70 Million | 0.089x | -78.20% |
| 1993-12-31 | $140.80 Million | $57.20 Million | 0.406x | -14.36% |
| 1992-12-31 | $212.50 Million | $100.80 Million | 0.474x | +17.10% |
| 1991-12-31 | $330.80 Million | $134.00 Million | 0.405x | -7.49% |
| 1990-12-31 | $256.70 Million | $112.40 Million | 0.438x | +101.25% |
| 1989-12-31 | $330.00 Million | $71.80 Million | 0.218x | -- |
About Laboratory Corporation of America Holdings
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and… Read more